Prostate Cancer

Radical Prostatectomy vs Active Surveillance: Results of Nearly 3 Decades of Follow-up

Radical Prostatectomy vs Active Surveillance: Results of Nearly 3 Decades of Follow-up

By

Researchers sought to determine the effect of radical prostatectomy vs watchful waiting on life expectancy in men with prostate cancer.

All-Grade AE Profiles Better Measure of Quality of Life in Metastatic Castration-Naïve Prostate Cancer

All-Grade AE Profiles Better Measure of Quality of Life in Metastatic Castration-Naïve Prostate Cancer

By

A study evaluating patient vs clinician reports of adverse events reveals which measures provide a more accurate perspective on patient quality of life.

Prostate Cancer Screening, Treatment Information in YouTube Videos Unreliable, Inaccurate

Prostate Cancer Screening, Treatment Information in YouTube Videos Unreliable, Inaccurate

By

Researchers sought to determine the quality and accuracy of information on prostate cancer disseminated through YouTube videos.

ADT May Up Risk for Heart Failure in Prostate Cancer Patients

ADT May Up Risk for Heart Failure in Prostate Cancer Patients

Heart failure risk was found to be higher for androgen deprivation therapy users in a propensity score-matched analysis.

Barriers to Prostate Cancer Research in Black Men Identified

Barriers to Prostate Cancer Research in Black Men Identified

Mistrust, lack of knowledge, unfavorable attitudes are barriers to genomic testing, study participation

Navigating Prostate Cancer: A Patient's Experience From Diagnosis to Survivor

Navigating Prostate Cancer: A Patient's Experience From Diagnosis to Survivor

By

Lee Hillstrom shares his cancer experience and highlights the critical support he received from a nurse navigator and cancer counselor.

LDR-BT Boost Plus EBRT, ADT Improves Survival in High-Risk Prostate Cancer

LDR-BT Boost Plus EBRT, ADT Improves Survival in High-Risk Prostate Cancer

By

Low-dose-rate brachytherapy, as an addition to radiation therapy and ADT, helps improve survival in high-risk prostate cancer, according to new study data.

Maintaining High Level of Activity Has Inverse Relationship With Prostate Cancer Risk

Maintaining High Level of Activity Has Inverse Relationship With Prostate Cancer Risk

By

Men who have physically demanding jobs may have a lower risk of prostate cancer than those who do not, according to study data.

Anxiety, Depression in Prostate Cancer: Managing Psychosocial Effects in Male Patients

Anxiety, Depression in Prostate Cancer: Managing Psychosocial Effects in Male Patients

By

A review of how emotions, social perceptions, and physical effects influence coping skills for men with prostate cancer.

CDC Reports Screening Drop in Breast, Cervical, and Prostate Cancers

CDC Reports Screening Drop in Breast, Cervical, and Prostate Cancers

By

CDC investigators found that from 2000 to 2015, screening for breast, cervical, and prostate cancers decreased significantly.

Hypnosis: A Comparison of the Efficacy of an Intervention Across Patient Populations

Hypnosis: A Comparison of the Efficacy of an Intervention Across Patient Populations

By

Researchers sought to determine if men with prostate cancer would derive the same benefits from hypnosis as women with breast cancer. Their results highlight significant differences in what is helpful for men vs women.

Dinner Hour and Sleep Habits Affect Risk of Breast, Prostate Cancers

Dinner Hour and Sleep Habits Affect Risk of Breast, Prostate Cancers

By

A population-based, case-control study identified a link between timing of meals and interval between last meal and sleep with risk of cancer, particularly of the breast and prostate.

Bariatric Surgery Reduced Risk of Some Cancers in Obese Patients

Bariatric Surgery Reduced Risk of Some Cancers in Obese Patients

By

Weight loss associated with bariatric surgery could reduce risk of hormone-related cancers, but an increased risk for colorectal cancer was seen in patients who underwent gastric bypass.

USPSTF Updates Guidelines for PSA-Based Screening for Prostate Cancer in Older Men

USPSTF Updates Guidelines for PSA-Based Screening for Prostate Cancer in Older Men

By

In updating its 2012 recommendations, the US Preventive Services Task Force changes its stance on PSA-based screening for prostate cancer in men older than 50. The new guidelines advocate for a patient-physician discussion of the benefits of testing vs the potential harms.

Overall Survival Benefit With Prostate Cancer Vaccine Not Duplicated in Phase 3 Trial

Overall Survival Benefit With Prostate Cancer Vaccine Not Duplicated in Phase 3 Trial

By

Latest findings do not confirm an overall survival (OS) benefit found in a previous randomized phase 2 trial.

No Improvement in OS, DFS With MP + Adjuvant ADT for High-Risk Prostate Cancer

No Improvement in OS, DFS With MP + Adjuvant ADT for High-Risk Prostate Cancer

By

The addition of mitoxantrone and prednisone (MP) to adjuvant androgen-deprivation therapy did not increase survival among patients with high-risk prostate cancer.

Smoking During Primary Therapy Worsens Oncologic Outcomes in Prostate Cancer

Smoking During Primary Therapy Worsens Oncologic Outcomes in Prostate Cancer

By

A meta-analysis of 11 studies revealed the effects of smoking outcomes of primary radical radiotherapy or radical prostatectomy for prostate cancer.

ADT Affects Sexual Function, Intimacy in Early Prostate Cancer Treatment

ADT Affects Sexual Function, Intimacy in Early Prostate Cancer Treatment

By

Researchers report on a study investigating effects of ADT on prostate cancer health-related quality of life, sexual function, sexual bother, and mood for patients with prostate cancer and their partners.

Drinking Wine in Moderation Does Not Appear to Impact Prostate Cancer Risk

Drinking Wine in Moderation Does Not Appear to Impact Prostate Cancer Risk

Interestingly, red and white wine to not affect prostate cancer risk the same way.

USPSTF: Decision to Undergo PSA Screening Should Be Individual

USPSTF: Decision to Undergo PSA Screening Should Be Individual

The decision to undergo periodic PSA screening for prostate cancer should be an individual one for men aged 55 to 69 years, according to the recommendation statement.

Lower Disease-Specific Mortality Seen With Early Detection of Prostate Cancer

Lower Disease-Specific Mortality Seen With Early Detection of Prostate Cancer

By

In an analysis of data from the SEER program, researchers determined that early detection of prostate cancer has let to an improvement in the number of men presenting with metastatic prostate cancer.

Challenges of Shared Decision Making in Prostate Cancer Screening

Challenges of Shared Decision Making in Prostate Cancer Screening

By

A review of shared decision making with men about undergoing PSA testing revealed that although full SDM discussions are increasing, variations in whether these discussions occur and how much information is shared still exist.

Long-term Prostate Cancer Risk Reduction Seen With Finasteride 

Long-term Prostate Cancer Risk Reduction Seen With Finasteride 

By

Finasteride recipients had a 21.1% decreased risk of prostate cancer compared with placebo recipients, researchers found.

PSA Screening Increases Prostate Cancer Detection, No Significant Difference in Mortality

PSA Screening Increases Prostate Cancer Detection, No Significant Difference in Mortality

By

Researchers conducted a randomized clinical study of men to determine the impact of PSA screening on prostate cancer detection and mortality.

Following False-Positive Results, Patients More Likely to Have Future Cancer Screenings

Following False-Positive Results, Patients More Likely to Have Future Cancer Screenings

The researchers found that the choice to undergo future screenings appeared to be influenced by previous false-positive results for both men and women.

Taxane Acute Pain Syndrome in Cancer Therapy: Occurrence, Impact on Quality of Life

Taxane Acute Pain Syndrome in Cancer Therapy: Occurrence, Impact on Quality of Life

By

Results of a prospective study of patients with breast or prostate cancer demonstrate the impact of taxane-based chemotherapy on quality of life.

Increased Monitoring Increases Cost, Not Quality of Care or Survival, in Prostate Cancer

Increased Monitoring Increases Cost, Not Quality of Care or Survival, in Prostate Cancer

By

In an evaluation of SEER-Medicare data, researchers sought to determine the benefits of extreme use of monitoring in patients with metastatic prostate cancer at the end of life on survival outcomes, quality of life, and costs.

Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance

Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance

By

ADT recipients reported worse subjective sleep disturbance, researchers found.

Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC

Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC

By

According to the FDA, the drug approval is the first to use the end point of metastasis-free survival.

Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer

Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer

Aggressive therapy does not appear to be more beneficial than conservative androgen deprivation therapy alone, according to a study.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs